| scholarly article | Q13442814 |
| P50 | author | Guanming Wu | Q59721408 |
| Aurora S Blucher | Q89111566 | ||
| P2093 | author name string | Shannon K McWeeney | |
| Lincoln Stein | |||
| P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
| DrugBank 4.0: shedding new light on drug metabolism | Q24568341 | ||
| ConsensusPathDB: toward a more complete picture of cell biology | Q24611619 | ||
| EGFR/HER-targeted therapeutics in ovarian cancer | Q26863231 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands | Q27136827 | ||
| DrugCentral: online drug compendium | Q27697588 | ||
| Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing | Q90636827 | ||
| Methodologies for the modeling and simulation of biochemical networks, illustrated for signal transduction pathways: a primer | Q38338647 | ||
| FDA-approved small-molecule kinase inhibitors. | Q38480289 | ||
| A comprehensive map of molecular drug targets. | Q39026969 | ||
| Querying quantitative logic models (Q2LM) to study intracellular signaling networks and cell‐cytokine interactions | Q41887989 | ||
| Genetic variants affecting equivalent protein family positions reflect human diversity. | Q42371793 | ||
| Understanding and targeting resistance mechanisms in NSCLC. | Q46915997 | ||
| Evidence-Based Precision Oncology with the Cancer Targetome. | Q47893147 | ||
| Steps forward for cancer precision medicine | Q49690497 | ||
| Precision Oncology: The Road Ahead. | Q50195535 | ||
| DrugCentral 2018: an update | Q58106086 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| The BioPAX community standard for pathway data sharing | Q27987775 | ||
| Stem cell factor and its receptor c-Kit as targets for inflammatory diseases | Q28115994 | ||
| Metabolic stability and epigenesis in randomly constructed genetic nets | Q28256189 | ||
| A quantitative analysis of kinase inhibitor selectivity | Q28264038 | ||
| The stem cell factor receptor/c-Kit as a drug target in cancer | Q28297193 | ||
| Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors | Q28475474 | ||
| Training signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli | Q28477321 | ||
| A survey of current trends in computational drug repositioning | Q28602324 | ||
| BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology | Q28603124 | ||
| Reactome: a knowledge base of biologic pathways and processes | Q28757721 | ||
| Drug target identification using side-effect similarity | Q29615103 | ||
| Oncogenic pathway signatures in human cancers as a guide to targeted therapies | Q29615526 | ||
| Global mapping of pharmacological space | Q29615876 | ||
| Cancer drug resistance: an evolving paradigm | Q29616694 | ||
| Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions. | Q30368617 | ||
| CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms | Q30573980 | ||
| ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis | Q30859718 | ||
| PANTHER pathway: an ontology-based pathway database coupled with data analysis tools | Q33481679 | ||
| A human functional protein interaction network and its application to cancer data analysis | Q33581341 | ||
| Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. | Q33597322 | ||
| PharmGKB: The Pharmacogenomics Knowledge Base | Q33855594 | ||
| Targeting the EGFR signaling pathway in cancer therapy | Q34246558 | ||
| The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer | Q34806737 | ||
| Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes | Q34901991 | ||
| The Reactome pathway Knowledgebase | Q35866115 | ||
| Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information | Q36434850 | ||
| Boolean network models of cellular regulation: prospects and limitations | Q36661749 | ||
| Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. | Q37485865 | ||
| Precision medicine driven by cancer systems biology | Q37742635 | ||
| State-time spectrum of signal transduction logic models | Q38032684 | ||
| Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways | Q38091054 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P304 | page(s) | 908 | |
| P577 | publication date | 2019-06-20 | |
| P1433 | published in | F1000Research | Q27701587 |
| P1476 | title | Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz | |
| P478 | volume | 8 |
| Q90611166 | Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma | cites work | P2860 |
Search more.